title: Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice.
abstract: Leishmania amazonensis causes different diseases depending on the host and parasitic virulence factors. In this study, CBA mice were infected with L. amazonensis isolates from patients with localized (Ba125), diffuse cutaneous (Ba276) or visceral leishmaniasis (Ba109). Mice infected with Ba125 and Ba276 progressed rapidly and lesions displayed an infiltrate rich in parasitized macrophages and were necrotic and ulcerated. Ba109 induced smaller lesions and a mixed inflammatory infiltrate without necrosis or ulceration. Ba109 induced an insidious disease with lower parasite load in CBA mice, similar to human disease. Levels of IFN-γ, IL-4 and IL-10 did not differ among the groups. Because all groups were unable to control the infection, expression of IL-4 associated with low production of IFN-γ in the early phase of infection may account for susceptibility, but others factors may contribute to the differences observed in inflammatory responses and infection progression. Evaluation of some parasitic virulence factors revealed that Ba276 exhibits higher ecto-ADPase and 5'-nucleotidase activities compared to the Ba109 and Ba125 strains. Both Ba276 and Ba125 had higher arginase activity in comparison to Ba109. Finally, these data suggest that the differences in enzyme activities among parasites can account for differences in host inflammatory responses and infection progression.
authors.affiliation: Centro de Pesquisas Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brasil.
authors.forename: Valderes L de
authors.initials: VL
authors.lastname: Souza
authors.forename: Patrícia S T
authors.initials: PS
authors.lastname: Veras
authors.forename: Marcus
authors.initials: M
authors.lastname: Welby-Borges
authors.forename: Tânia M C
authors.initials: TM
authors.lastname: Silva
authors.forename: Bruna R
authors.initials: BR
authors.lastname: Leite
authors.forename: Rodrigo B
authors.initials: RB
authors.lastname: Ferraro
authors.forename: José R
authors.initials: JR
authors.lastname: Meyer-Fernandes
authors.forename: Aldina
authors.initials: A
authors.lastname: Barral
authors.forename: Jackson Mauricio Lopes
authors.initials: JM
authors.lastname: Costa
authors.forename: Luiz A R
authors.initials: LA
authors.lastname: de Freitas
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000469:parasitology; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D007371:Interferon-gamma / Q000096:biosynthesis*; D016753:Interleukin-10 / Q000096:biosynthesis*; D015847:Interleukin-4 / Q000096:biosynthesis*; D007894:Leishmania mexicana / Q000201:enzymology / Q000276:immunology / Q000472:pathogenicity*; D016773:Leishmaniasis, Cutaneous / Q000276:immunology* / Q000473:pathology; D007898:Leishmaniasis, Visceral / Q000276:immunology* / Q000473:pathology; D008099:Liver / Q000469:parasitology; D051379:Mice; D008808:Mice, Inbred CBA; D013154:Spleen / Q000469:parasitology; D037521:Virulence Factors / Q000276:immunology
chemical_list: D037521:Virulence Factors; D016753:Interleukin-10; D015847:Interleukin-4; D007371:Interferon-gamma